Clinical Trial Search

Primary: New Tissue Thickness — 5.40; 5.70; 5.50 millimeters

Primary: Venous Thromboembolic Events (VTE) — 26; 14 participants — p=0.042

Primary: Peak Spatial Frequency Radius at the Site of Pathology — 2.180; 2.146; 2.194; 2.184 mm^-1

Primary: Pain (Aim 1) — 4.9; 5.2; 1.8; 1.5 units on a scale

Primary: Reduce Calf Muscle Atrophy — 859.8; 874.9; 1450.4; 1634.9 mm^2

Primary: Central Sensitization — 463.5; 383.6; 425.7; 358.0 kilopascal — p=0.44

Primary: Syndesmotic Volumetric Ratio — 1.2; 1.1 Volumetric Ratio

Primary: Change in Cross-sectional Area at the Place of Maximum Tendon Width — 0.8; 0.76; 0.78; 0.69 cm^2 — p=0.722

Primary: Victorian Institute of Sports Assessment - Achilles (VISA-A) — 37.55; 43.82; 36.08; 46.92 score on a scale

Primary: Calf Raises Performed to Fatigue and Inability to Continue — 3; 8; 5 Calf raises

Primary: Assessment of Functional Outcomes Following Agility LP Ankle Replacement — 37.67; 37.07 Degrees

Primary: The Western Ontario Rotator Cuff (WORC) Patient Reported Outcome (PRO) Score at Week 14 in All Patients - Statistical Analysis Results of Total WORC Scores at Week 14…

Primary: Pain Following a Total Ankle Replacement as Measured by the Visual Analog Scale (VAS) for Pain — 67.0; 71.3; 16.7; 18.6 mm — p=0.29

Primary: Foot Function Index(FFI) — 16.0; 12.7; 8.1; 8.3 units on a scale

Primary: Pain Assessment — 52.73; 33.00; 17.00; 21.25 score on a scale

Primary: Change in Tendon Thickness — 1.7; 2.6; 1.2; 1.2 millimeters

Primary: Change From Baseline in the Western Ontario Rotator Cuff (WORC) Patient Reported Outcome (PRO) Percentage Score at Week 24 — 55.7; 46.8 Score on a Scale

Primary: Percent Change From Baseline in the Rectified and Integrated EMG Signal of the Tibialis Anterior Muscle At 24 Weeks Post-Operative — 1333 % change

Primary: Medial Clear Space Distance in the Ankle Joint — 1.41 mm

Primary: Participant Pain Assessment — -3.9; -2.2; -3.6; -4.3 units on a scale — p=0.33

Primary: Success in Terms of the Merle D'Aubigne Postel Score for Pain Category — 4.1; 4.4; 4.5; 4.6 Units on a scale

Primary: Proportion of Subjects Who Met All Five Criteria for Subject Performance Composite (SPC) Endpoint — 79.5; 35.3 percentage of subjects

Primary: Clinical Success Rate at 6 Months — 58; 68 Participants

Primary: Number of Participants Who Completed Semi-structured Interviews — 18; 0; 8; 12 Participants

Primary: Change of Pain During Activity From Baseline to 3 Months After Intervention — -1.4; -1.5; -3.0 units on a scale — p=0.35

Primary: Change in Elbow Pain Using Visual Analog Scale (VAS) — 5.1; 3.0; 1.9; 1.1 VAS Score

Primary: Normative Isokinetic Knee Extension Strength, Measured in Newton Meters (Nm) at 26 Weeks Post-op — 0.881; 0.681 Nm — p=0.0498

Primary: Mortality — 111; 112; 133; 130 Participants

Primary: Change From Baseline in Visual Analog Scale (VAS) at 6 and 12 Weeks — 3.57; 3.02; 2.93; 1.60 score on a scale — p=0.52

Primary: Total Estimated Blood Loss — 40.41; 18.75 ml